Sintilimab + GC

DRUG2 trials

Sponsors

Fudan University, Eastern Hepatobiliary Surgery Hospital

Conditions

Advanced Intrahepatic CholangiocarcinomaBiliary Tract Cancer (BTC)

Phase 2

Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC

Not yet recruitingNCT07152769

Fudan UniversityAdvanced Intrahepatic Cholangiocarcinoma

Start: 2025-10-15End: 2028-12-31Target: 104Updated: 2025-09-03

Efficacy and Safety of SBRT Plus Gemcitabine, Cisplatin, and Sintilimab as First-Line Treatment for Unresectable Biliary Tract Cancer

Not yet recruitingNCT07638501

Eastern Hepatobiliary Surgery HospitalBiliary Tract Cancer (BTC)

Start: 2026-06-15End: 2029-06-15Target: 123Updated: 2026-06-10